1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | LPA was unable to interview R1. To further investigate the allegation, on November 13, 2025, LPA contacted Local Ombudsman office. On April 10, 2026, LPA requested additional documents. During interviews, all staff stated all medications are given as prescribed by the physician and all residents have signed consent. During interviews, all residents stated staff have never given them medication that was not prescribed to them. A review of the Medication Administration Records indicates during the time in question resident was taking Levetiracetam/Keppra twice daily for seizures. The Medication Administration Records did not indicate R1 was taking Depakote/Divalproex Sodium/Valproate Sodium or any other medication for seizures. A review of the Centrally Stored Medication and Destruction Record does not show R1 had the alleged Depakote/ Divalproex Sodium/Valproate Sodium centrally stored with the facility. A review of R1’s records shows R1 or their responsible party signed the Consent to a Medical Examination, Consent for Emergency Medical Treatment, and Release of Client/Resident Medical Information forms. The Local Ombudsman stated they were not given authorization to release the information to the LPA.
Based on interviews and record review, there is not enough information to verify the allegation, therefore, the allegation is UNSUBSTANTIATED at this time.
No health and safety hazards noted during the visit.
Exit interview conducted. Copy of this report issued.
|